Reviewed November 16, 2026
Benchling
PrivateLife-sciences research platform
Company overview
- Revenue
- ~$210M ARR
- May 2024 · Estimate
- Reference valuation
- $6.1B
- Historical Series F · Nov 2021
- Primary customer
- Biotech and pharmaceutical scientists[1]
- Commercial model
- Software subscriptions[1]
Revenue is an independently estimated measure. The valuation is a dated transaction reference, not a current appraisal.[1]
Revenue history
Revenue
ARR · USD
+14%
May 2024 vs. Dec 2023 · calculated change; not annualized
| Period | USD | Evidence |
|---|---|---|
| $185M | Estimate | |
| $210M | Estimate |
Sacra · company research and financial history ↗
ARR observations are point-in-time measures, not completed annual revenue.
Points show dated observations at equal spacing; intervening performance is not measured.
Products, customers & revenue model
Business economics
- What drives the business
- Enterprise deployments require services. Customer expansion and implementation economics both matter.[1]
Leadership & functional coverage
Selected leaders supported by the linked sources; dated appointments retain their source context. This is not a complete org chart. Advisory roles are labeled.
| Leader | Role | Function / context |
|---|---|---|
| Sajith Wickramasekara | Cofounder & CEO | Company leadership[2] |
| Ashu Singhal | Cofounder | Company leadership[2] |
| Ron Gill | Finance leadership | Function listed in company leadership directory[2] |
| Meg Makalou | People leadership | Function listed in company leadership directory[2] |
| Julie Hwang | Legal leadership | Function listed in company leadership directory[2] |
| Brent Mosher | Customer Experience leadership | Function listed in company leadership directory[2] |
| Yvonne Chen | Marketing leadership | Function listed in company leadership directory[2] |
| Vineet Gopal | Technology leadership | Function listed in company leadership directory[2] |
Dated financial disclosures
Open research questions
- ↗How much recurring revenue comes from large pharma versus venture-funded biotech?
Sources & definitions
Financial history preserves the source’s measurement basis. ARR, annualized revenue, completed-year sales and transaction volume are distinct. Product economics are Plank analysis of the cited business model; open questions are not asserted findings.